These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 21862549)

  • 1. New Zealand bans synthetic cannabinoids.
    Brown K
    BMJ; 2011 Aug; 343():d5395. PubMed ID: 21862549
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthetic cannabinoid analogues--not repeating past mistakes.
    Schep LJ; Slaughter RJ; Temple WA; Nair SM; Gee PA
    N Z Med J; 2011 Apr; 124(1332):85-6. PubMed ID: 21747429
    [No Abstract]   [Full Text] [Related]  

  • 3. [Synthetic cannabinoids--the new "legal high" drugs].
    Berkovitz R; Arieli M; Marom E
    Harefuah; 2011 Dec; 150(12):884-7, 937. PubMed ID: 22352277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Notes from the Field: Increase in Reported Adverse Health Effects Related to Synthetic Cannabinoid Use - United States, January-May 2015.
    Law R; Schier J; Martin C; Chang A; Wolkin A;
    MMWR Morb Mortal Wkly Rep; 2015 Jun; 64(22):618-9. PubMed ID: 26068566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spice drugs as a new trend: mode of action, identification and legislation.
    Vardakou I; Pistos C; Spiliopoulou Ch
    Toxicol Lett; 2010 Sep; 197(3):157-62. PubMed ID: 20566335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Synthetic drugs: the new low-cost landscape of drugs].
    Karila L; Petit A; Cottencin O; Coscas S; Reynaud M
    Rev Prat; 2012 May; 62(5):664-6. PubMed ID: 22730798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Getting up to speed with the public health and regulatory challenges posed by new psychoactive substances in the information age.
    Griffiths P; Evans-Brown M; Sedefov R
    Addiction; 2013 Oct; 108(10):1700-3. PubMed ID: 23865891
    [No Abstract]   [Full Text] [Related]  

  • 8. New psychoactive substances: issues about the new approach from New Zealand government.
    von Diemen L
    Addiction; 2014 Oct; 109(10):1588-9. PubMed ID: 25163704
    [No Abstract]   [Full Text] [Related]  

  • 9. Recent developments with the establishment of a regulated legal market for new psychoactive substances ('legal highs') in New Zealand.
    Wilkins C
    Drug Alcohol Rev; 2014 Nov; 33(6):678-80. PubMed ID: 25302553
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug marketing exclusivity under United States and European Union law.
    Junod V
    Food Drug Law J; 2004; 59(4):479-518. PubMed ID: 15875347
    [No Abstract]   [Full Text] [Related]  

  • 11. Gonzales v. Raich: federalism as a casualty of the war on drugs.
    Somin I
    Cornell J Law Public Policy; 2006; 15(3):507-50. PubMed ID: 17593582
    [No Abstract]   [Full Text] [Related]  

  • 12. A bad trip: lawmakers try to stay one step ahead of the chemists manufacturing dangerous synthetic drugs.
    Lawrence A
    State Legis; 2011 Jun; 37(6):28-9. PubMed ID: 21667572
    [No Abstract]   [Full Text] [Related]  

  • 13. Importing prescription drugs: risky business.
    Hassel L; Arzuaga P
    Empl Benefits J; 2003 Dec; 28(4):83-6. PubMed ID: 14712740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alarm over synthetic cannabinoids.
    Underwood E
    Science; 2015 Jan; 347(6221):473. PubMed ID: 25635070
    [No Abstract]   [Full Text] [Related]  

  • 15. The emerging threat of synthetic cannabinoids.
    Phillips J; Lim F; Hsu R
    Nurs Manage; 2017 Mar; 48(3):22-30. PubMed ID: 28234762
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA bans 223 ingredients in nonprescription drug products.
    Clin Pharm; 1991 Feb; 10(2):88, 93. PubMed ID: 2009736
    [No Abstract]   [Full Text] [Related]  

  • 17. Where is the pleasure?
    Ritter A
    Addiction; 2014 Oct; 109(10):1587-8. PubMed ID: 25163703
    [No Abstract]   [Full Text] [Related]  

  • 18. [The change of the new veterinary drug legislation for delivery of veterinary drugs].
    Schutte F
    Tijdschr Diergeneeskd; 2006 Jan; 131(2):54-5. PubMed ID: 16454094
    [No Abstract]   [Full Text] [Related]  

  • 19. Rethinking the regulatory framework for tobacco control in New Zealand.
    Thomson G; Wilson N; Crane J
    N Z Med J; 2005 Apr; 118(1213):U1405. PubMed ID: 15843834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDA appointment is stalled as revelations emerge over Plan B.
    Tanne JH
    BMJ; 2006 Aug; 333(7563):317. PubMed ID: 16902205
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.